Glavine Paulinsider trades
In SEC Form 4 filings, Glavine Paul is listed as Chief Growth Officer of Helus Pharma Inc. (HELP). In the last 90 days, Glavine Paul bought $4.72M of Cybin Inc. (CYBN) on the open market and sold none. The largest purchase was $1.25M of Cybin Inc. (CYBN) on Sep 8.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| HELPHelus Pharma Inc. | Chief Growth Officer | 5 | Oct 1 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-09
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| HELPHelus Pharma Inc. | Sep 30 | Oct 1 | A | 248,000 | not reported | not reported | 4,750,191 | No | Form 4 |
| CYBNCybin Inc. | Sep 8 | Sep 11 | P | 100,000 | $12.47 | Purchase +$1,247,190 | 4,271,252 | No | Form 4 |
| CYBNCybin Inc. | Sep 8 | Sep 11 | P | 100,000 | $12.47 | Purchase +$1,247,190 | 4,271,252 | No | Form 4 |
| CYBNCybin Inc. | Sep 3 | Sep 10 | P | 100,000 | $11.78 | Purchase +$1,178,280 | 4,171,252 | No | Form 4 |
| CYBNCybin Inc. | Aug 31 | Sep 9 | P | 90,000 | $11.59 | Purchase +$1,042,677 | 4,071,252 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.